1,255 Shares in The Clorox Company (NYSE:CLX) Purchased by Fifth Third Wealth Advisors LLC

Fifth Third Wealth Advisors LLC bought a new stake in The Clorox Company (NYSE:CLX) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 1,255 shares of the company’s stock, valued at approximately $204,000.

Other hedge funds also recently modified their holdings of the company. R.H. Investment Group LLC purchased a new position in shares of Clorox during the fourth quarter valued at approximately $325,000. Exeter Financial LLC lifted its stake in shares of Clorox by 2.6% during the 4th quarter. Exeter Financial LLC now owns 7,986 shares of the company’s stock worth $1,297,000 after purchasing an additional 199 shares during the period. Courier Capital LLC boosted its holdings in shares of Clorox by 4.2% during the fourth quarter. Courier Capital LLC now owns 2,495 shares of the company’s stock worth $405,000 after purchasing an additional 100 shares during the last quarter. Miracle Mile Advisors LLC purchased a new stake in shares of Clorox in the fourth quarter valued at $1,566,000. Finally, Fiduciary Alliance LLC increased its stake in Clorox by 64.9% in the fourth quarter. Fiduciary Alliance LLC now owns 2,432 shares of the company’s stock valued at $395,000 after purchasing an additional 957 shares during the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Stock Down 0.1 %

Shares of Clorox stock opened at $160.31 on Friday. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.37. The business has a 50-day moving average of $164.25 and a 200-day moving average of $156.38. The company has a market capitalization of $19.84 billion, a PE ratio of 55.86, a P/E/G ratio of 2.90 and a beta of 0.42.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the previous year, the business earned $0.49 EPS. Clorox’s revenue for the quarter was up 27.0% compared to the same quarter last year. As a group, equities analysts forecast that The Clorox Company will post 6.87 EPS for the current fiscal year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be paid a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a yield of 3.04%. Clorox’s dividend payout ratio (DPR) is 170.04%.

Wall Street Analysts Forecast Growth

Several analysts have commented on the company. StockNews.com cut Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Evercore ISI dropped their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research report on Monday, October 14th. Jefferies Financial Group upgraded shares of Clorox from a “hold” rating to a “buy” rating and lifted their price target for the company from $174.00 to $187.00 in a report on Tuesday, October 1st. Wells Fargo & Company upgraded Clorox from an “underweight” rating to an “equal weight” rating and upped their price objective for the stock from $155.00 to $157.00 in a report on Tuesday, January 7th. Finally, JPMorgan Chase & Co. lifted their target price on Clorox from $167.00 to $171.00 and gave the company a “neutral” rating in a report on Thursday. Four investment analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Clorox currently has a consensus rating of “Hold” and an average target price of $156.54.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.